{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:55:33Z","timestamp":1790128533492,"version":"4.0.1"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,7,24]],"date-time":"2006-07-24T00:00:00Z","timestamp":1153699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To determine the impact of highly active antiretroviral therapy (HAART) on the incidence and outcomes of Kaposi's sarcoma (KS), non\u2010Hodgkin's lymphoma (NHL) and invasive cervical cancer\/dysplasia in a well\u2010defined geographical HIV\u2010infected population between 1984 and 2005.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A clinic database search, chart review and verification with public health records were undertaken for all AIDS\u2010defining cancers diagnosed in Southern Alberta before and after the introduction of HAART.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2137 patients with 9265 person\u2010years of HIV follow\u2010up care were reviewed. One hundred and forty\u2010three cases of KS, 64 cases of NHL and 11 cases of invasive cervical cancer\/dysplasia were identified. KS and NHL together accounted for 15% of clinical presentations with an AIDS\u2010defining illness that led to the HIV diagnosis. Following the introduction of HAART, the reduced number of severely immunocompromised patients was associated with 92 and 84% reductions in new diagnoses of KS and NHL, respectively, which were seen mainly in clinic patients declining or failing HAART. Crude reductions of 94 and 65% in mortality from KS and NHL, respectively, were also seen. The prevalences of KS, NHL and invasive cervical cancer\/dysplasia have recently stabilized at 3, 1 and 5% of the population, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The introduction of HAART has dramatically reduced the incidence of KS and NHL and improved survival from these cancers for most patients in HIV care. However, patients still present with KS and NHL leading to their HIV diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2006.00395.x","type":"journal-article","created":{"date-parts":[[2006,7,24]],"date-time":"2006-07-24T22:17:54Z","timestamp":1153779474000},"page":"369-377","source":"Crossref","is-referenced-by-count":17,"title":["The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS\u2010defining cancers in Southern Alberta"],"prefix":"10.1111","volume":"7","author":[{"given":"S","family":"Gingues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"Castro HG","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2004.18.501"},{"key":"e_1_2_6_4_2","first-page":"1380","article-title":"Trends in AIDS\u2010defining and non\u2010AIDS\u2010defining malignancies among HIV\u2010infected patients","volume":"39","author":"Bedimo R","year":"2004","journal-title":"1989\u20132002"},{"key":"e_1_2_6_5_2","first-page":"387","article-title":"[Epidemiology of HIV\u2010associated malignancies] [French]","volume":"90","author":"Launay O","year":"2003","journal-title":"Bull Cancer"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1479"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200409000-00006"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00271.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200409000-00010"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.22.1823"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/375781"},{"key":"e_1_2_6_13_2","first-page":"10","article-title":"Starting highly active antiretroviral therapy","volume":"54","author":"Mocroft A","year":"2004","journal-title":"why, when and response to HAART"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200409000-00008"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200309000-00007"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200108170-00005"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910220-00014"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00011"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900117"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00013"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.18.3848"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200204)32:4<1080::AID-IMMU1080>3.0.CO;2-R"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00002"},{"key":"e_1_2_6_24_2","first-page":"952","article-title":"Long\u2010term remission of AIDS\u2010related primary central nervous system lymphoma associated with highly active antiretroviral therapy","volume":"12","author":"McGowan JP","year":"1998","journal-title":"AIDS"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11816"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10274"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.6.2634-2640.2002"},{"key":"e_1_2_6_28_2","first-page":"673","article-title":"Systemic non\u2010Hodgkin lymphoma in individuals with known dates of HIV seroconversion","volume":"18","author":"Bhaskaran K","year":"2004","journal-title":"incidence and predictors"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162043351237"},{"key":"e_1_2_6_30_2","first-page":"146","article-title":"Kaposi's sarcoma","volume":"87","author":"Schwartz RA.","year":"2004","journal-title":"an update"},{"key":"e_1_2_6_31_2","first-page":"86","article-title":"[Kaposi's sarcoma during HIV infection in Morocco (apropos of 50 cases)] [French]","volume":"96","author":"Chakib A","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"e_1_2_6_32_2","first-page":"8","article-title":"Case report","volume":"3","author":"Young AC","year":"2001","journal-title":"Kaposi's sarcoma: an unusual presentation"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-7646(03)00060-8"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(03)00043-1"},{"key":"e_1_2_6_35_2","first-page":"787","article-title":"AIDS\u2010related cancer in the era of highly active antiretroviral therapy (HAART)","volume":"22","author":"Cheung TW.","year":"2004","journal-title":"a model of the interplay of the immune system, virus, and cancer. \u2018On the offensive \u2013 the Trojan Horse is being destroyed\u2019\u2013 Part B. Malignant lymphoma"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/154.6.544"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200308150-00007"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/380129"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.547"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2006.00395.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2006.00395.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:11:39Z","timestamp":1696961499000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2006.00395.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,24]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1111\/j.1468-1293.2006.00395.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2006.00395.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,24]]}}}